Company intelligence / Profile preview

Satiety Solutions

Mountain View, California, United States

Ownership: Private
Development stage: Other

Overview

Satiety, Inc. was a venture-backed medical device company focused on developing less invasive, endoscopic treatments for obesity. The company's flagship product was the TOGA (Transoral Gastroplasty) System, designed to create a restrictive pouch in the stomach without the need for traditional surgery. By using an endoscopic approach, the procedure aimed to mimic the effects of gastric stapling while reducing recovery time and surgical risks. Despite raising significant venture capital and conducting clinical trials, the company ceased operations around 2011 after failing to secure further funding or a strategic exit.

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Satiety Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Satiety Solutions.

Explore the full profile